Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

513
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
513
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

855
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
855
Common Respiratory Disorders01:31

Common Respiratory Disorders

1.3K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

462
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
462
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

788
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
788

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

Chest·2026
Same author

A Cross-Sectional Investigation of Relationships between Food Pleasure and Worry, Eating Behaviors, and Cultural Attributes among Mexican American Adults.

International journal of gastronomy and food science·2026
Same author

Evaluation of Large Language Models for Structured Data Extraction From Interstitial Lung Disease Clinical Notes: Comparative Study.

Journal of medical Internet research·2026
Same author

Beyond counting: how single-cell long-read sequencing turns transcriptome complexity into precision targets.

Frontiers in oncology·2026
Same author

Associations Between Caregiver Smartphone Use in a Child's Presence and Motor Skills and Executive Function in Preschoolers: SUNRISE International Study.

Child: care, health and development·2026
Same author

Changes in Sugar-Sweetened Beverage Intake From Before to After Nutrition Labeling Policy Implementation: A Comparison of Mexico and the United States.

Preventing chronic disease·2026

Related Experiment Video

Updated: Jan 17, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.8K

Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes.

Aartik Sarma1,2,3, Stephanie A Christenson1, Beth Shoshana Zha1

  • 1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine.

American Journal of Respiratory and Critical Care Medicine
|September 25, 2025
PubMed
Summary

Acute respiratory distress syndrome (ARDS) has two distinct molecular phenotypes: hyperinflammatory and hypoinflammatory. Hyperinflammatory ARDS shows unique lung biology, including increased interferon-stimulated gene expression and T-cell activation.

Keywords:
ARDSRNA sequencingmolecular phenotypesprecision medicine

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.8K
Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

10.3K

Related Experiment Videos

Last Updated: Jan 17, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.8K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.8K
Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

10.3K

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Genomics

Background:

  • Two molecular phenotypes of acute respiratory distress syndrome (ARDS), hyperinflammatory and hypoinflammatory, have been identified based on plasma biomarkers.
  • These phenotypes exhibit different clinical outcomes and treatment responses.
  • However, the distinct pulmonary biology underlying these ARDS phenotypes remains largely unexplored.

Purpose of the Study:

  • To elucidate the differences in pulmonary biology between the hyperinflammatory and hypoinflammatory ARDS molecular phenotypes.
  • To investigate gene expression patterns in tracheal aspirates and plasma proteomic data.

Main Methods:

  • Compared tracheal aspirate gene expression using bulk and single-cell RNA sequencing (RNASeq) in COVID-19 and non-COVID-19 ARDS cohorts.
  • Analyzed plasma proteomic data in a subset of subjects.
  • Utilized gene set enrichment analysis and network analysis to identify differentially expressed genes and pathways.

Main Results:

  • Identified significant differences in gene expression between ARDS phenotypes in both COVID-19 and non-COVID-19 cohorts.
  • Eighteen genes, including IL32, HSPA8, and PPP3CC, were consistently upregulated in hyperinflammatory ARDS.
  • Enriched pathways in hyperinflammatory ARDS included granulopoiesis, T-cell signaling, and integrated stress response, confirmed by single-cell RNASeq.

Conclusions:

  • Distinct respiratory system biology characterizes the hyperinflammatory and hypoinflammatory ARDS molecular phenotypes.
  • Hyperinflammatory ARDS is associated with heightened lung immune responses, specifically increased interferon-stimulated gene expression and T-cell activation.